Algorithmiq
About Algorithmiq
Algorithmiq develops quantum algorithms and interfaces that integrate classical and quantum computing to accelerate research in healthcare and life sciences. The company focuses on chemistry and drug discovery, materials science, and related life-science applications, using quantum computing to tackle complex, atomistic-scale problems. It promotes a Digital Quantum Interface to connect quantum hardware with existing computational workflows. Headquartered in Finland, Algorithmiq positions itself at the intersection of quantum computing and biomedical innovation.
Recent News
Quantum Computing Partnership Targets Faster Design of Advanced Functional Materials
Algorithmiq Shifts HQ to Milan, Secures $19.4M in Italy's Largest Quantum VC Deal
Wellcome Leap Announces $2M Prize in $50M Quantum for Bio Challenge Program
Simulating Heat with Quantum Particles Unlocks New Materials Science Possibilities
Finland’s Algorithmiq Takes Top Spot in $50M Q4Bio Challenge with Quantum Drug Simulation Milestone
Cleveland Clinic Catalyzer Program Awards $250K to Quantum Startups
Helsinki’s Algorithmiq Wins €1.7 Million Prize for Quantum-Enabled Light-Sensitive Cancer Drug Discovery